Show Summary Details
Page of

Oral versus IV Steroids for Acute Relapses of Multiple Sclerosis 

Oral versus IV Steroids for Acute Relapses of Multiple Sclerosis
Oral versus IV Steroids for Acute Relapses of Multiple Sclerosis

Joshua Lovinger

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 01 December 2020

This chapter provides a summary of a landmark study in multiple sclerosis. Are oral steroids as effective as intravenous steroids in treatment of acute relapses of multiple sclerosis? Starting with that question, it describes the basics of the study, including funding, study location, who was studied, how many patients, study design, study intervention, follow-up, endpoints, results, and criticism and limitations. Oral steroids appear to be equally efficacious in treating MS exacerbations relative to IV steroids, are considerably cheaper, and do not require hospital admission; however, due to concerns about higher rates of recurrent optic neuritis with oral versus IV steroids, some continue to prefer IV treatment for exacerbations. The chapter briefly reviews other relevant studies and information, and concludes with a relevant clinical case.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.